Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REViSION: Extended vs Single Dose Cefazolin in Revision Arthroplasty
NCT06402591Phase 3Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2019
- Primary completion
- Dec 2023
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of cefazolin in periprosthetic joint infection (PJI), sponsored by Radboud University Medical Center. Started Jan 2019; status: active, not recruiting.
02
Drugs
cefazolin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT06402591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402591.